March 17, 2010

Medco, Mayo Clinic study finds reduced hospitalization rates with genetic testing


A simple genetic test can reduce hospitalization rates by almost a third for heart patients taking warfarin, the world's most-prescribed blood thinner, according to a study released today by researchers from Medco Health Solutions, Inc. (in association with the Medco Research Institute) and the Mayo Clinic…


"The test provides the information a physician needs to more precisely dose a patient so that an individual who has a low sensitivity to the drug can be dosed higher to minimize the risk of stroke and someone who is highly sensitive to the drug can be given a lower dose to avoid bleeding," said Thomas P. Moyer at Mayo Clinic's Department of Laboratory Medicine and Pathology and co-author of the study.


Healthcare IT News, by Mike Milliard, 3/15/2010


Additional coverage:



National Post

Tags: blood thinner, Cardiology, Genetic testing, MD, Medco, Thomas Moyer

Please sign in or register to post a reply.
Contact Us · Privacy Policy